Our Recommendations
- Paludisme | Guides médicaux MSF (2025)
- Paludismo | Guías de práctica clínica MSF (2025)
- Basic malaria microscopy. Part 1: Learner's guide (2020)
- Malaria diagnostics technology and market landscape. 3rd edition (2022)
- Microscopie pour la détection, l’identification et la quantification des parasites du paludisme sur frottis sanguins ou gouttes épaisses colorés dans les environnements de recherche (2020)
New Publications
- Malarial Parasite: – Part 1 – Plasmodium Life Cycle and Diagnosis (2025)
- Clinical profile of malaria and HIV co-infection (2020)
- Tackling antimalarial drug resistance (2020)
- Regional stakeholder meeting on the response to antimalarial drug resistance in Africa (2024)
- Extending the WHO scheme for external quality assessment of nucleic acid amplification testing for monitoring antimalarial drug resistance: meeting report, 14 July 2023 (2025)
Filter
90
Featured
Recommendations
6
New Publications
9
Language
Document type
Guidelines
37
Studies & Reports
15
Manuals
9
Training Material
6
Fact sheets
6
Resource Platforms
5
Infographics
5
No document type
5
Online Courses
1
Strategic & Response Plan
1
Countries / Regions
Global
17
Mozambique
5
Brazil
3
Angola
3
Benin
1
Africa
1
Oman
1
Uganda
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Pharmacy & Technologies
23
Clinical Guidelines
22
Countries
5
Women & Child Health
4
Capacity Building
1
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
Chapitre 50. Le texte traite du paludisme grave, une forme sévère du paludisme principalement causée par Plasmodium falciparum. Il explique les circonstances dans lesquelles le diagnostic doit être évoqué, notamment en cas de fièvre au retour d'une zone tropicale. Le document décrit les exam...
The webpage from Medicines for Malaria Venture (MMV) focuses on efforts to develop and provide child-friendly antimalarial treatments. It highlights the challenges of treating malaria in children, who are among the most vulnerable to the disease, and the need for safe, effective, and easy-to-adminis...
The "Pocket Manual for the Diagnosis and Treatment of Malaria", published by the Ministry of Health of the Sultanate of Oman, provides practical guidance for healthcare professionals on how to identify, manage, and treat malaria cases. It emphasizes parasitological confirmation before treatment, out...
Paludisme | Guides médicaux MSF
recommended
La page intitulée « Paludisme » sur le site des Guides médicaux de Médecins Sans Frontières (MSF) fournit des directives cliniques détaillées pour le diagnostic, le traitement et la prévention du paludisme, en particulier dans les contextes humanitaires et les zones à ressources limitées....
Paludismo | Guías de práctica clínica MSF
recommended
La página titulada «Paludismo» en el sitio de las Guías médicas de Médicos Sin Fronteras (MSF) proporciona directrices clínicas detalladas para el diagnóstico, tratamiento y prevención del paludismo, especialmente en contextos humanitarios y en zonas con recursos limitados. Describe las dis...
La page du site VIDAL intitulée « Paludisme : traitement – Recommandations » présente les recommandations actuelles pour la prise en charge du paludisme. Elle détaille les différents traitements selon le type de paludisme (P. falciparum ou non), la gravité de l'infection (simple ou sévère...
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.
Pour combattre et éliminer le paludisme, il est essentiel de disposer de médicaments antipaludiques efficaces. Un suivi régulier de l’efficacité des médicaments s’impose pour orienter les politiques de traitement dans les pays d’endémie palustre et assurer la détection précoce de la ph...
Para controlar y eliminar el paludismo (o malaria) es fundamental contar con fármacos antipalúdicos eficaces. Para fundamentar las políticas de tratamiento en los países donde esta enfermedad es endémica, y para garantizar la pronta detección de toda farmacorresistencia y una adecuada respuest...
Front. Malar. 3:1336324. doi: 10.3389/fmala.2025.1336324
L’article « Traitement du paludisme d’importation de l’enfant » sur le site Pas à Pas en Pédiatrie traite de la prise en charge médicale du paludisme chez les enfants revenant de zones endémiques. Il décrit les différents types de paludisme, les symptômes à reconnaître, les critère...
Mozambique was the first country outside of the Sahel to successfully implement seasonal malaria chemoprevention (SMC) on a large scale. This learning paper captures some of the lessons drawn from the implementation process.
Moçambique foi o primeiro país fora da região do Sahel a expandir com sucesso a quimioprevenção sazonal da malária (QSM). Neste documento de aprendizagem, descrevemos as lições decorrentes da aplicação em larga escala da QSM em Moçambique.
Where malaria transmission is seasonal, notably in Africa’s Sahel region, children of all ages most at risk of severe malaria are protected through SMC. This intervention consists of full antimalarial treatment courses of sulfadoxine-pyrimethamine and amodiaquine (SPAQ), administered monthly (28 d...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Lecture. Accessed July, 2025
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
